Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 6:40 PM
Ignite Modification Date:
2025-12-25 @ 4:11 PM
NCT ID:
NCT02761057
Group ID:
EG002
Title:
Crizotinib
Description:
Experimental: Arm III (crizotinib closed to accrual 12/5/18) Patients receive crizotinib PO BID on days 1-42. Cycles repeat every 42 days in the absence of disease progression or unacceptable toxicity.
Drug: Crizotinib Given PO
Other Names:
CRIZOTINIB MET Tyrosine Kinase Inhibitor PF-02341066 PF-02341066 PF-2341066 Xalkori
Deaths Number Affected:
16
Deaths Number At Risk:
None
Serious Number Affected:
8
Serious Number At Risk:
27
Other Number Affected:
26
Other Number At Risk:
27
Study:
NCT02761057
Results Section:
NCT02761057
Adverse Events Module:
NCT02761057